|
1
|
Libby P, Ridker PM and Hansson GK:
Progress and challenges in translating the biology of
atherosclerosis. Nature. 473:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tabas I, García-Cardeña G and Owens GK:
Recent insights into the cellular biology of atherosclerosis. J
Cell Biol. 209:13–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kolodgie FD, Burke AP, Farb A, Gold HK,
Yuan J, Narula J, Finn AV and Virmani R: The thin-cap
fibroatheroma: A type of vulnerable plaque: The major precursor
lesion to acute coronary syndromes. Curr Opin Cardiol. 16:285–292.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pal AS and Kasinski AL: Animal models to
study MicroRNA function. Adv Cancer Res. 135:53–118. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bernardo BC, Ooi JY, Lin RC and McMullen
JR: miRNA therapeutics: A new class of drugs with potential
therapeutic applications in the heart. Future Med Chem.
7:1771–1792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karnati HK, Panigrahi MK, Gutti RK, Greig
NH and Tamargo IA: miRNAs: Key players in neurodegenerative
disorders and epilepsy. J Alzheimers Dis. 48:563–580. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mehrgou A and Akouchekian M: Therapeutic
impacts of microRNAs in breast cancer by their roles in regulating
processes involved in this disease. J Res Med Sci. 22:1302017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang SC, Wang M, Wu WB, Wang R, Cui J, Li
W, Li ZL, Li W and Wang SM: Mir-22-3p inhibits arterial smooth
muscle cell proliferation and migration and neointimal hyperplasia
by targeting HMGB1 in arteriosclerosis obliterans. Cell Physiol
Biochem. 42:2492–2506. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Q, Yang F, Guo M, Wen G, Zhang C,
Luong le A, Zhu J, Xiao Q and Zhang L: miRNA-34a reduces neointima
formation through inhibiting smooth muscle cell proliferation and
migration. J Mol Cell Cardiol. 89:75–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu J, Liu B, Wang Z, Wang D, Ni H, Zhang
L and Wang Y: Exosomes from nicotine-stimulated macrophages
accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC
migration and proliferation. Theranostics. 9:6901–6919. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Jiang M, Xu Z, Huang H, Gong P,
Zhu H and Ruan C: miR-146b-5p promotes VSMC proliferation and
migration. Int J Clin Exp Pathol. 8:12901–12907. 2015.PubMed/NCBI
|
|
13
|
Parekh AB and Putney JW Jr: Store-operated
calcium channels. Physiol Rev. 85:757–810. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takahashi Y, Watanabe H, Murakami M, Ono
K, Munehisa Y, Koyama T, Nobori K, Iijima T and Ito H: Functional
role of stromal interaction molecule 1 (STIM1) in vascular smooth
muscle cells. Biochem Biophys Res Commun. 361:934–940. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Potier M, Gonzalez JC, Motiani RK,
Abdullaev IF, Bisaillon JM, Singer HA and Trebak M: Evidence for
STIM1- and Orai1-dependent store-operated calcium influx through
ICRAC in vascular smooth muscle cells: Role in proliferation and
migration. FASEB J. 23:2425–2437. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Giachini FR, Lima VV, Hannan JL, Carneiro
FS, Webb RC and Tostes RC: STIM1/Orai1-mediated store-operated
Ca2+ entry: The tip of the iceberg. Braz J Med Biol Res.
44:1080–1087. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lopes J, Adiguzel E, Gu S, Liu SL, Hou G,
Heximer S, Assoian RK and Bendeck MP: Type VIII collagen mediates
vessel wall remodeling after arterial injury and fibrous cap
formation in atherosclerosis. Am J Pathol. 182:2241–2253. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rudijanto A: The role of vascular smooth
muscle cells on the pathogenesis of atherosclerosis. Acta Med
Indones. 39:86–93. 2007.PubMed/NCBI
|
|
20
|
Pan J, Lu L, Wang X, Liu D, Tian J, Liu H,
Zhang M, Xu F and An F: AIM2 regulates vascular smooth muscle cell
migration in atherosclerosis. Biochem Biophys Res Commun.
497:401–409. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Cheng H, Yue Y, Li S, Zhang D and
He R: H19 knockdown suppresses proliferation and induces apoptosis
by regulating miR-148b/WNT/beta-catenin in ox-LDL-stimulated
vascular smooth muscle cells. J Biomed Sci. 25:112018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li L, Li Y and Tang C: The role of
microRNAs in the involvement of vascular smooth muscle cells in the
development of atherosclerosis. Cell Biol Int. 43:1102–1112. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong S, Xiong W, Yuan J, Li J, Liu J and
Xu X: miRNA-146a regulates the maturation and differentiation of
vascular smooth muscle cells by targeting NF-κB expression. Mol Med
Rep. 8:407–412. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Zhang C, Li C, Zhao D, Li S, Ma L,
Cui Y, Wei X, Zhao Y and Gao Y: MicroRNA-92a promotes vascular
smooth muscle cell proliferation and migration through the
ROCK/MLCK signalling pathway. J Cell Mol Med. 23:3696–3710. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu CX, Xu L, Peng FZ, Cai YL and Wang YG:
miR-647 promotes proliferation and migration of ox-LDL-treated
vascular smooth muscle cells through regulating PTEN/PI3K/AKT
pathway. Eur Rev Med Pharmacol Sci. 23:7110–7119. 2019.PubMed/NCBI
|
|
26
|
Lu YJ, Liu RY, Hu K and Wang Y: miR-541-3p
reverses cancer progression by directly targeting TGIF2 in
non-small cell lung cancer. Tumour Biol. 37:12685–12695. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mao YY, Wang JQ, Guo XX, Bi Y and Wang CX:
Circ-SATB2 upregulates STIM1 expression and regulates vascular
smooth muscle cell proliferation and differentiation through
miR-939. Biochem Biophys Res Commun. 505:119–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ge C, Zeng B, Li R, Li Z, Fu Q, Wang W,
Wang Z, Dong S, Lai Z, Wang Y, et al: Knockdown of STIM1 expression
inhibits non-small-cell lung cancer cell proliferation in vitro and
in nude mouse xenografts. Bioengineered. 10:425–436. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng H, Wang S and Feng R: STIM1 plays an
important role in TGF-β-induced suppression of breast cancer cell
proliferation. Oncotarget. 7:16866–16878. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim JH, Lkhagvadorj S, Lee MR, Hwang KH,
Chung HC, Jung JH, Cha SK and Eom M: Orai1 and STIM1 are critical
for cell migration and proliferation of clear cell renal cell
carcinoma. Biochem Biophys Res Commun. 448:76–82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aoki M and Fujishita T: Oncogenic roles of
the PI3K/AKT/mTOR axis. Curr Top Microbiol Immunol. 407:153–189.
2017.PubMed/NCBI
|
|
32
|
Linton MF, Moslehi JJ and Babaev VR: Akt
signaling in macrophage polarization, survival, and
atherosclerosis. Int J Mol Sci. 20:27032019. View Article : Google Scholar
|
|
33
|
Zhai C, Cheng J, Mujahid H, Wang H, Kong
J, Yin Y, Li J, Zhang Y, Ji X and Chen W: Selective inhibition of
PI3K/Akt/mTOR signaling pathway regulates autophagy of macrophage
and vulnerability of atherosclerotic plaque. PLoS One.
9:e905632014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou M, Ren P, Zhang Y, Li S, Li M, Li P,
Shang J, Liu W and Liu H: Shen-Yuan-Dan capsule attenuates
atherosclerosis and foam cell formation by enhancing autophagy and
inhibiting the PI3K/Akt/mTORC1 signaling pathway. Front Pharmacol.
10:6032019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yao X, Yan C, Zhang L, Li Y and Wan Q:
LncRNA ENST00113 promotes proliferation, survival, and migration by
activating PI3K/Akt/mTOR signaling pathway in atherosclerosis.
Medicine (Baltimore). 97:e04732018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou Y, Gu P, Li J, Li F, Zhu J, Gao P,
Zang Y, Wang Y, Shan Y and Yang D: Suppression of STIM1 inhibits
the migration and invasion of human prostate cancer cells and is
associated with PI3K/Akt signaling inactivation. Oncol Rep.
38:2629–2636. 2017. View Article : Google Scholar : PubMed/NCBI
|
